Maybe accurate in the future but I think these numbers are too high at the moment
The HY indicates that 1.36m in revenue was from bioimplants. Assuming that it is 1200-1300 per patch it's in line with the "over 1000 patients implanted" comment.
Based on these numbers, with the new statement that 1200 have been implanted and assuming that there are delays in publishing, I think it would be more accurate to assume that the current levels indicate ~200 operations/month. This would indicate a revenue of $3.12m/year.
Ann: Admedus expands CardioCel market, page-28
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $344.2M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 681 | $17.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.25 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |